the staff of the Ridgewood blog
Ridgewood NJ, in a groundbreaking development, the U.S. Food and Drug Administration (FDA) has approved the first-ever nasal spray to treat potentially severe allergic reactions. The new spray, marketed under the brand name Neffy, offers a needle-free alternative to traditional injectable epinephrine products like the EpiPen, which has been in use since 1987.